Abstract Although control of Covid-19 has improved, the virus continues to cause infections, such as tuberculosis, that is still endemic in many countries, representing a scenario of coinfection. To compare Covid-19 clinical manifestations and outcomes between patients with active tuberculosis infection and matched controls. This is a matched case-control study based on data from the Brazilian Covid-19 Registry, in hospitalized patients aged 18 or over with laboratory confirmed Covid-19 from March 1, 2020, to March 31, 2022. Cases were patients with tuberculosis and controls were Covid-19 patients without tuberculosis. From 13,636 Covid-19, 36 also had active tuberculosis (0.0026%). Pulmonary fibrosis (5.6% vs 0.0%), illicit drug abuse (30.6% vs 3.0%), alcoholism (33.3% vs 11.9%) and smoking (50.0% vs 9.7%) were more common among patients with tuberculosis. They also had a higher frequency of nausea and vomiting (25.0% vs 10.4%). There were no significant differences in in-hospital mortality, mechanical ventilation, need for dialysis and ICU stay. Patients with TB infection presented a higher frequency of pulmonary fibrosis, abuse of illicit drugs, alcoholism, current smoking, symptoms of nausea and vomiting. The outcomes were similar between them. Covid19 Covid 19 Covid-1 improved infections countries coinfection casecontrol case Registry 1 2020 31 2022 13636 13 636 13,63 Covid19, 19, 3 0.0026%. 00026 0.0026% . 0 0026 (0.0026%) 5.6% 56 5 6 (5.6 0.0%, 00 0.0% , 0.0%) 30.6% 306 30 (30.6 3.0%, 3.0% 3.0%) 33.3% 333 33 (33.3 11.9% 119 11 9 50.0% 500 50 (50.0 9.7% 97 7 25.0% 250 25 (25.0 10.4%. 104 10.4% 10 4 10.4%) inhospital hospital mortality ventilation stay drugs them Covid1 Covid- 202 1363 63 13,6 0002 0.0026 002 (0.0026% 5.6 (5. 0.0 30.6 (30. 3.0 33.3 (33. 11.9 50.0 (50. 9.7 25.0 2 (25. 10.4 20 136 13, 000 0.002 (0.0026 5. (5 0. 30. (30 3. 33. (33 11. 50. (50 9. 25. (25 10. 0.00 (0.002 ( (3 (2 (0.00 (0.0 (0. (0

Abstract Objective To evaluate clinical characteristics and outcomes of COVID-19 patients infected with HIV, and to compare with a paired sample without HIV infection. Methods This is a substudy of a Brazilian multicentric cohort that comprised two periods (2020 and 2021). Data was obtained through the retrospective review of medical records. Primary outcomes were admission to the intensive care unit, invasive mechanical ventilation, and death. Patients with HIV and controls were matched for age, sex, number of comorbidities, and hospital of origin using the technique of propensity score matching (up to 4:1). They were compared using the Chi-Square or Fisher's Exact tests for categorical variables and the Wilcoxon for numerical variables. Results Throughout the study, 17,101 COVID-19 patients were hospitalized, and 130 (0.76%) of those were infected with HIV. The median age was 54 (IQR: 43.0;64.0) years in 2020 and 53 (IQR: 46.0;63.5) years in 2021, with a predominance of females in both periods. People Living with HIV (PLHIV) and their controls showed similar prevalence for admission to the ICU and invasive mechanical ventilation requirement in the two periods, with no significant differences. In 2020, in-hospital mortality was higher in the PLHIV compared to the controls (27.9% vs. 17.7%; p = 0.049), but there was no difference in mortality between groups in 2021 (25.0% vs. 25.1%; p > 0.999). Conclusions Our results reiterate that PLHIV were at higher risk of COVID-19 mortality in the early stages of the pandemic, however, this finding did not sustain in 2021, when the mortality rate is similar to the control group. COVID19 COVID 19 COVID-1 infection (202 2021. . 2021) records unit death sex comorbidities up 41. 41 4 1 4:1) ChiSquare Chi Square Fishers Fisher s study 17101 17 101 17,10 hospitalized 13 0.76% 076 0 76 (0.76% 5 IQR (IQR 43.064.0 430640 43.0 64.0 43 64 43.0;64.0 202 46.063.5 460635 46.0 63.5 46 63 46.0;63.5 (PLHIV differences inhospital 27.9% 279 27 9 (27.9 vs 17.7% 177 7 0.049, 0049 0.049 , 049 0.049) 25.0% 250 25 (25.0 25.1% 251 0.999. 0999 0.999 999 0.999) pandemic however group COVID1 COVID- (20 4:1 1710 10 17,1 0.76 07 (0.76 064 43.064. 43064 430 43. 640 64. 6 43.0;64. 20 063 46.063. 46063 460 46. 635 63. 46.0;63. 27.9 2 (27. 17.7 004 0.04 04 25.0 (25. 25.1 099 0.99 99 (2 4: 171 17, 0.7 (0.7 06 43.064 4306 43.0;64 46.063 4606 46.0;63 27. (27 17. 00 0.0 25. (25 09 0.9 ( 0. (0. 43.06 43.0;6 46.06 46.0;6 (0 43.0; 46.0;

Abstract Background Despite no evidence showing benefits of hydroxychloroquine and chloroquine with or without azithromycin for COVID-19 treatment, these medications have been largely prescribed in Brazil. Objectives To assess outcomes, including in-hospital mortality, electrocardiographic abnormalities, hospital length-of-stay, admission to the intensive care unit, and need for dialysis and mechanical ventilation, in hospitalized COVID-19 patients who received chloroquine or hydroxychloroquine, and to compare outcomes between those patients and their matched controls. Methods A retrospective multicenter cohort study that included consecutive laboratory-confirmed COVID-19 patients from 37 Brazilian hospitals from March to September 2020. Propensity score was used to select matching controls by age, sex, cardiovascular comorbidities, and in-hospital use of corticosteroid. A p-value <0.05 was considered statistically significant. Results From 7,850 COVID-19 patients, 673 (8.6%) received hydroxychloroquine and 67 (0.9%) chloroquine. The median age in the study group was 60 years (46 - 71) and 59.1% were women. During hospitalization, 3.2% of patients presented side effects and 2.2% required therapy discontinuation. Electrocardiographic abnormalities were more prevalent in the chloroquine/hydroxychloroquine group (13.2% vs. 8.2%, p=0.01), and the long corrected QT interval was the main difference (3.6% vs. 0.4%, p<0.001). The median hospital length of stay was longer in the HCQ/CQ + AZT group than in controls (9.0 [5.0, 18.0] vs. 8.0 [4.0, 14.0] days). There was no statistical differences between groups in intensive care unit admission (35.1% vs. 32.0%; p=0.282), invasive mechanical ventilation support (27.0% vs. 22.3%; p=0.074) or mortality (18.9% vs. 18.0%; p=0.682). Conclusion COVID-19 patients treated with chloroquine or hydroxychloroquine had a longer hospital length of stay, when compared to matched controls. Intensive care unit admission, invasive mechanical ventilation, dialysis and in-hospital mortality were similar. COVID19 COVID 19 COVID-1 treatment Brazil inhospital lengthofstay, lengthofstay length-of-stay laboratoryconfirmed laboratory confirmed 3 2020 sex comorbidities corticosteroid pvalue p value 005 0 05 <0.0 significant 7850 7 850 7,85 8.6% 86 8 6 (8.6% 0.9% 09 9 (0.9% 46 (4 71 591 59 1 59.1 women hospitalization 32 2 3.2 22 2.2 discontinuation chloroquinehydroxychloroquine 13.2% 132 13 (13.2 vs 82 8.2% p=0.01, p001 p=0.01 , 01 p=0.01) 3.6% 36 (3.6 04 4 0.4% p<0.001. p0001 p<0.001 . 001 p<0.001) HCQCQ HCQ CQ 9.0 90 (9. 5.0, 50 5 [5.0 18.0 180 18 80 8. 4.0, 40 [4.0 14.0 140 14 days. days days) 35.1% 351 35 (35.1 32.0% 320 p=0.282, p0282 p=0.282 282 p=0.282) 27.0% 270 27 (27.0 22.3% 223 p=0.074 p0074 074 18.9% 189 (18.9 18.0% p=0.682. p0682 p=0.682 682 p=0.682) similar COVID1 COVID- 202 00 <0. 785 85 7,8 8.6 (8.6 0.9 (0.9 ( 59. 3. 2. 13.2 (13. 8.2 p00 p=0.0 3.6 (3. 0.4 p000 p<0.00 9. (9 5.0 [5. 18. 4.0 [4. 14. 35.1 (35. 32.0 p028 p=0.28 28 27.0 (27. 22.3 p=0.07 p007 07 18.9 (18. p068 p=0.68 68 20 <0 78 7, (8. 0. (0. 13. (13 p0 p=0. (3 p<0.0 5. [5 4. [4 35. (35 32. p02 p=0.2 27. (27 22. (18 p06 p=0.6 < (8 (0 (1 p=0 p<0. [ (2 p= p<0 p<

Resumo Fundamento Apesar da ausência de evidência mostrando benefícios da hidroxicloroquina e da cloroquina combinadas ou não à azitromicina no tratamento da covid-19, esses medicamentos têm sido amplamente prescritos no Brasil. Objetivos Avaliar desfechos, incluindo moralidade hospitalar, alterações eletrocardiográficas, tempo de internação, admissão na unidade de terapia intensiva, e necessidade de diálise e de ventilação mecânica em pacientes hospitalizados com covid-19 que receberam cloroquina ou hidroxicloroquina, e comparar os desfechos entre aqueles pacientes e seus controles pareados. Métodos Estudo multicêntrico retrospectivo do tipo coorte que incluiu pacientes com diagnóstico laboratorial de covid-19 de 37 hospitais no Brasil de março a setembro de 2020. Escore de propensão foi usado para selecionar controles pareados quanto a idade, sexo, comorbidades cardiovasculares, e uso de corticosteroides durante a internação. Um valor de p<0,05 foi considerado estatisticamente significativo. Resultados Dos 7850 pacientes com covid-19, 673 (8,6%) receberam hidroxicloroquina e 67 (0,9%) cloroquina. A idade mediana no grupo de estudo foi 60 (46-71) anos e 59,1% eram mulheres. Durante a internação, 3,2% dos pacientes apresentaram efeitos adversos e 2,2% necessitaram de interromper o tratamento. Alterações eletrocardiográficas foram mais prevalentes no grupo hidroxicloroquina/cloroquina (13,2% vs. 8,2%, p=0,01), e o prolongamento do intervalo QT corrigido foi a principal diferença (3,6% vs. 0,4%, p<0,001). O tempo mediano de internação hospitalar foi maior no grupo usando CQ/HCQ em relação aos controles (9,0 [5,0-18,0] vs. 8,0 [4,0-14,0] dias). Não houve diferenças estatisticamente significativas entre os grupos quanto a admissão na unidade de terapia intensiva (35,1% vs. 32,0%; p=0,282), ventilação mecânica invasiva (27,0% vs. 22,3%; p=0,074) ou mortalidade (18,9% vs. 18,0%; p=0,682). Conclusão Pacientes com covid-19 tratados com cloroquina ou hidroxicloroquina apresentaram maior tempo de internação hospitalar, em comparação aos controles. Não houve diferença em relação a admissão em unidade de terapia intensiva, necessidade de ventilação mecânica e mortalidade hospitalar. covid19, covid19 covid 19, 19 covid-1 3 2020 sexo cardiovasculares p005 p 0 05 p<0,0 significativo 785 8,6% 86 8 6 (8,6% 0,9% 09 9 (0,9% 4671 46 71 (46-71 591 59 1 59,1 mulheres 32 2 3,2 22 2,2 hidroxicloroquinacloroquina 13,2% 132 13 (13,2 vs 82 8,2% p=0,01, p001 p=0,01 , 01 p=0,01) 3,6% 36 (3,6 04 4 0,4% p<0,001. p0001 p<0,001 . 001 p<0,001) CQHCQ CQ HCQ 9,0 90 (9, 5,018,0 50180 5,0 18,0 5 18 [5,0-18,0 80 8, 4,014,0 40140 4,0 14,0 14 [4,0-14,0 dias. dias dias) 35,1% 351 35 (35,1 32,0% 320 p=0,282, p0282 p=0,282 282 p=0,282) 27,0% 270 27 (27,0 22,3% 223 p=0,074 p0074 074 18,9% 189 (18,9 18,0% 180 p=0,682. p0682 p=0,682 682 p=0,682) covid1 covid- 202 p00 p<0, 78 8,6 (8,6 0,9 (0,9 467 7 (46-7 59, 3, 2, 13,2 (13, 8,2 p=0,0 3,6 (3, 0,4 p000 p<0,00 00 9, (9 018 5,018, 5018 50 5, 18, [5,0-18, 014 4,014, 4014 40 4, 140 14, [4,0-14, 35,1 (35, 32,0 p028 p=0,28 28 27,0 (27, 22,3 p=0,07 p007 07 18,9 (18, p068 p=0,68 68 20 p0 p<0 (8, 0, (0, (46- 13, (13 p=0, (3 ( 5,018 501 [5,0-18 4,014 401 [4,0-14 35, (35 32, p02 p=0,2 27, (27 22, (18 p06 p=0,6 p< (8 (0 (46 (1 p=0 5,01 [5,0-1 4,01 [4,0-1 (2 (4 p= [5,0- [4,0- [5,0 [4,0 [5, [4, [5 [4 [

Resumo Objetivo Avaliar a efetividade do uso de protocolos de triagem avançada no tempo de permanência, segurança e satisfação dos pacientes e profissionais no serviço de emergência. Método Revisão sistemática com metanálise de ensaios clínicos randomizados das bases de dados Embase, BVS, PubMed, CINAHL, Cochrane Library e literatura cinza, utilizando o Review Manager 5.4. Foram incluídos estudos que analisaram tempo de permanência em seus desfechos e excluídos estudos que consideraram outros protocolos de triagem. Resultados Foram encontrados 26.672 estudos, revisados por pares, e dez foram incluídos na metanálise. Para tempo de permanência dos pacientes, sete estudos foram incluídos na metanálise (n=8.229), mostrando uma redução de 36 minutos (-0,36[-0,55; -0,17] p=0,002), resultado com baixa certeza de evidências, favorável à intervenção, variando entre -0,53(-0,81; - 0,25) e -0,29(-0,50; -0,07) na análise dos subgrupos. Quanto aos exames solicitados, cinco estudos foram incluídos (n=2270), indicando que não há diferença significativa entre os grupos (odds ratio 0,94 [0,64;1,38]). Quatro estudos (n=6094) analisaram a satisfação dos pacientes e profissionais, apontando um resultado favorável à intervenção. Conclusão O protocolo de triagem avançada reduziu o tempo de permanência na emergência sem comprometer a segurança e a qualidade do atendimento, embora sejam necessários mais estudos clínicos randomizados sobre o tema. Registrado na PROSPERO (CRD42019142640).

Abstract Objective To evaluate the effectiveness of using advanced triage protocols on the length of stay, safety and satisfaction of the patients and professionals in the emergency department. Method A systematic review with meta-analysis of randomized clinical trials included in the Embase, BVS, PubMed, CINAHL, Cochrane Library databases and in the gray literature, using Review Manager 5.4. Studies that analyzed length of stay in their outcomes were included and the studies excluded were those that considered other triage protocols. Results 26,672 peer-reviewed studies were found and ten were included in the meta-analysis. For the patients’ length of stay, seven studies were included in the meta-analysis (n=8,229), showing a 36-minute reduction (-0.36[-0.55;-0.17] p=0.002), a result with low certainty of evidence, favorable to the intervention, varying between -0.53 (-0.81;- 0.25) and -0.29 (-0.50;-0.07) in the analysis of the subgroups. Regarding the exams requested, five studies were included (n=2,270), indicating that there is no significant difference between the groups (odds ratio 0.94 [0.64;1.38]). Four studies (n=6,094) analyzed the patients’ and the professionals’ satisfaction, indicating a favorable result to the intervention. Conclusion The advanced triage protocol reduced length of stay in the emergency room without compromising care safety and quality, although more randomized clinical studies on the theme are needed. Registered in PROSPERO (CRD42019142640).

Resumen Objetivo Evaluar la efectividad del uso de protocolos de triage avanzado en la duración de la estancia, seguridad y satisfacción de los pacientes y profesionales en el servicio de emergencia. Método Revisión sistemática con metaanálisis de ensayos clínicos aleatorizados de las bases de datos Embase, BVS, PubMed, CINAHL, Cochrane Library y de la literatura gris, utilizando Review Manager 5.4. Se incluyeron los estudios que analizaron la duración de la estancia en sus resultados y se excluyeron los estudios que consideraron otros protocolos de triage. Resultados Se encontraron 26.672 estudios, fueron revisados por pares y diez se incluyeron en el metaanálisis. Para la duración de la estancia de los pacientes, se incluyeron siete estudios en el metaanálisis (n=8.229), que muestran una reducción de 36 minutos (-0,36 [-0,55; -0,17] p=0,002), un resultado con baja certeza de la evidencia, favorable a la intervención, que osciló entre -0,53(-0,81;-0,25) y -0,29(-0,50;-0,07) en el análisis de los subgrupos. En cuanto a las pruebas solicitadas, se incluyeron cinco estudios (n=2270) que indican que no hay diferencia significativa entre los grupos (odds ratio 0,94 [0,64; 1,38]). Cuatro estudios (n=6094) analizaron la satisfacción de los pacientes y profesionales e indican que la intervención tuvo un resultado favorable. Conclusión El protocolo de triage avanzado redujo la estancia en el servicio de emergencia sin comprometer la seguridad y la calidad de la atención, aunque es necesario que se realicen más ensayos clínicos aleatorizados sobre el tema. Registrado en PROSPERO (CRD42019142640).

RESUMO Objetivo O objetivo deste estudo foi investigar o impacto de lesões dentais traumáticas severas na Qualidade de Vida Relacionada à Saúde Bucal (QVRSB) de crianças pré-escolares. Métodos Estudo transversal realizado com crianças de 2 a 5 anos e suas mães, na cidade de Pelotas / RS. A escala Early Childhood Oral Health Impact Scale (ECOHIS) foi aplicada para avaliar a percepção das mães sobre a QVRSB das crianças. O exame de saúde bucal incluiu traumatismo dentário, classificado como ausente / leve (fratura de esmalte apenas) ou severo, o número de dentes decíduos cariados, ausentes ou restaurados (ceo-d) e a presença de mordida aberta anterior. O impacto do traumatismo dentário severo na QVRSB foi avaliado por meio de análise de regressão logística (P <0,05). Resultados Foram incluídos 599 pré-escolares e 7,4% sofreram traumatismo dentário severo. Destes, 73,3% apresentaram impacto negativo na QVRSB (p = 0,044). Após ajustes, as crianças com traumatismo dentário severo tiveram um impacto na QVRSB 110% maior do que aquelas sem trauma / com trauma leve (OR: 2,10, IC 95% 1,01-4,35). Traumas dentais graves causaram impacto negativo nos domínios sintomas orais (OR: 2,13, IC 95% 1,10-4,14), domínio psicológico (OR: 2,13, IC 95% 1,10-4,13) e função familiar (OR: 2,79, IC 95% 1,17-6,61). Conclusão A presença de traumatismo dentário severo impacta a QVRSB de crianças pré-escolares e suas famílias.

ABSTRACT Objective: The aim of this study was to investigate the impact of severe traumatic dental injuries on the Oral Health related Quality of Life (OHRQoL) of preschool children. Methods: This cross-sectional study was conducted with children aged 2 to 5 years and their mothers, in Pelotas/ Brazil Southern. The Early Childhood Oral Health Impact Scale (ECOHIS) was applied to assess the perception of mothers about children’s OHRQoL. Oral examination included dental trauma, categorized as absent/mild (enamel fracture only) or severe, the number of decayed, missing or restored primary teeth (dmft), and presence of anterior open bite. The impact of severe dental trauma on OHRQoL was evaluated using logistic regression analysis (P<0.05). Results: A total of 599 preschool children were included and 7.4% had severe dental trauma. Of these 73.3% showed negative impact on OHRQoL (p= 0.044). After adjustments, children with severe dental trauma had an impact in OHRQoL 110% higher than those without/with mild trauma (OR: 2.10, 95% CI 1.01-4.35). Severe dental injuries caused negative impact on the oral symptoms (OR: 2.13, 95% CI 1.10-4.14), psychological (OR: 2.13, 95% CI 1.10-4.13) and family function (OR: 2.79, 95% CI 1.17-6.61) domains. Conclusion: The presence of severe dental trauma impacts the OHRQoL of preschool children and their families.

RESUMO: Apesar do volume de leite produzido, a qualidade da matéria-prima é um dos maiores entraves ao desenvolvimento tecnológico e à consolidação da indústria de laticínios no Brasil. Dentre os entraves, toma destaque a contagem de células somáticas do leite, que é o indicador mais usado em programas de controle e prevenção da mastite em todo o mundo. Com objetivo de identificar características no manejo de ordenha e quantificar fatores de risco que elevam a mastite subclínica e seus principais agentes causadores, realizou-se coleta de dados in loco em propriedades leiteiras na região Oeste do Paraná, coletas que consistiam na aplicação de dois questionários guia semi-estruturados, acompanhamento de uma ordenha e coleta de leite de três vacas que apresentassem o teste de CMT positivo. Com a utilização do método estatístico de análise de correspondência múltipla (ACM) chegou-se a um montante de 12 variáveis a serem estudadas e a formação das dimensões 1 e 2 com 28,54% e 21,06% da variância explicada respectivamente. Com a análise de classificação hierárquica ascendente permitiu reduzir o universo inicial de 112 vacas para quatro grupos homogêneos de produção (G1, G2, G3, G4). As características de manejo de ordenha: tipo de ordenha, secagem dos tetos antes da ordenha, tratamento para casos de mastite clínica, higiene das mãos do ordenhador e treinamento dos ordenadores foram identificados como fatores de risco para mastite subclínica com isolamento do agente Staphylococcus coagulase negativo, o qual foi o agente mais prevalente nos isolamentos microbiológicos das amostras de leite com mastite subclínica.

ABSTRACT: Despite the produced milk volume, its quality is one of the barriers for technological development and consolidation of the dairy industry in Brazil. Among the barriers is the milk somatic cell count, which is the indicator used in most control programs and prevention of mastitis. In order to identify characteristics in the management of milking and to quantify risk factors that increase subclinical mastitis and its main bacterial agents, data were collected in situ on dairy farms in western Paraná. The data collection consisted in the application of two questionnaires, in accompanying a milking procedure, and in collection of CMT positive milk samples from three cows. Using the statistical method of multiple correspondence analysis (MCA) we came to a total of 12 variables to be studied, and to the formation of dimension 1 and 2 with respectively 28.54% and 21.06% of the explained variance. With the hierarchical ascending classification analysis it was possible to reduce the initial population of 112 cows to produce four homogeneous groups (G1, G2, G3, G4). The milking handling characteristics, as type of milking, drying teats before milking, treatment for cases of clinical mastitis, milker’s hand hygiene and as training of officers, were identified as risk factors for subclinical mastitis with isolation of a coagulase negative Staphylococcus, which was the most prevalent agent in milk samples of subclinical mastitis.

ABSTRACT The objective of the study was to evaluate the replacement of Tifton 85 hay (TH) for Tifton 85 silage (TS) in the diets of lactating cows. Five Holstein cows in middle of lactation were allocated in a 5 × 5 Latin square design and each experimental period lasted 18 days (12 days for adaptation and six days for collection). Treatments consisted of replacement of 0, 25, 50, 75, and 100% of TH for TS. The intake and digestion of nutrients, microbial protein synthesis, milk yield and composition, and the economic viability of the diets were evaluated. The intakes of dry matter, organic matter, and ether extract had a positive linear effect and the digestibility of dry matter, organic matter, crude protein, neutral detergent fiber, acid detergent fiber decreased linearly with increasing participation of TS. Milk production and composition and microbial protein synthesis were not affected. Regarding economic viability, the treatment with 100% hay produced better results, with better gross margin. The Tifton 85 silage can be used as a replacement for Tifton 85 hay up to 100% without changing the milk production and composition of Holstein cows.

Resumo Este estudo teve como objetivo verificar a interferência do consumo de diferentes bebidas artesanais a base de carboidratos durante o treinamento sobre as concentrações plasmáticas de lactato e glicose e sensação afetiva de atletas da modalidade de Ginástica Rítmica (GR). O estudo foi desenvolvido com 10 atletas (14 a 19 anos) de GR, realizados em três dias consecutivos (1° dia: controle G1; 2° dia: Suplemento 1 G2; 3° dia: Suplemento 2 G3), com ingestão da bebida em três momentos distintos: no início do treino, 1 hora e 2 horas após. Os resultados permitem concluir que os suplementos foram eficientes para manter os níveis glicêmicos, além disso, as bebidas artesanais a base de carboidratos proporcionaram maior sensação de prazer diante do esforço realizado, principalmente o G3.

Abstract This study aimed to verify the influence of the consumption of different handmade drinks containing carbohydrates during training on lactate and glucose concentration and affective feeling of Rhythmic Gymnastics (RG) athletes. The study was conducted with 10 athletes (14-19 years) of RG, performed during three consecutive days (1st day: control G1, 2nd day: Supplement 1 G2, 3rd day: Supplement 2 G3), with intake at three different times: at the beginning of training, 1 hour and 2 hours after. The results showed that the supplements were effective in maintaining glucose; moreover, the handmade drinks containing carbohydrates provided greater sense of pleasure at the efforts, especially in G3.

Resumen Este estudio tuvo como objetivo verificar la influencia del consumo de diferentes bebidas preparadas artesanalmente que contienen hidratos de carbono durante el entrenamiento en la concentración plasmática de lactato y glucosa, y el sentimiento afectivo de atletas de gimnasia rítmica (GR). El estudio se llevó a cabo con 10 atletas (14-19 años) de GR, realizado durante 3 días consecutivos (primer día: control G1; segundo día: suplemento 1 G2, y tercer día: suplemento 2 G3), con la ingesta de la bebida en tres momentos diferentes: al comienzo del entreno, 1 hora y 2 horas después. Los resultados mostraron que los suplementos fueron efectivos en el mantenimiento de los niveles de glucosa; además, las bebidas preparadas artesanalmente que contienen hidratos de carbono proporcionan mayor sensación de placer por los esfuerzos realizados, especialmente en G3.

ABSTRACT The objective of this study was to determine the optimal level of dried brewers' grains (DBG) to replace soybean meal in diets for lactating Holstein cows. Five cows, around 88±28 days in milk, were distributed in a 5 × 5 Latin square design and fed diets containing different levels of DBG (0, 25, 50, 75, and 100%). The forage:concentrate ratio of the diet was 50:50. Feed intake, dry matter, nutrient digestibility, microbial synthesis, milk production and composition, and the economic viability of the diets were evaluated. There was reduction in dry matter intake and, consequently, in crude protein and non-fiber carbohydrates with increased levels of DBG. This occurred due to physical limitation of rumen caused by increased neutral detergent fiber intake. Ether extract intake also increased with levels of DBG due to higher concentrations of this nutrient in the diet. Apparent dry matter, organic matter, ether extract, and neutral detergent fiber digestibility increased with replacement of soybean meal by DBG. Milk production showed a quadratic effect and the levels of fat, protein, and total solids reduced linearly. Each 1% of soybean meal replaced by DBG in concentrate led to a reduction of 0.04, 0.02, and 0.06 g kg-1 of milk fat, protein, and total solids, respectively. The milk production efficiency increased linearly and the microbial synthesis efficiency was not affected. The economic return increased along with the DBG levels. Thus, DBG levels replacing up to 75% of soybean meal can be used to feed lactating cows, since it provides improvements in digestibility, milk production efficiency, and economic return without affecting microbial efficiency.

RESUMO Objetivos Identificar desigualdades socioeconômicas e regionais na cobertura de exames citopatológicos do colo do útero no Rio Grande do Sul. Métodos Estudo ecológico utilizou dados dos sistemas de informação em saúde de 2011-2012 para estimar coberturas anuais de exames para todas as mulheres residentes e para as não beneficiárias de planos privados de saúde. Desigualdades na cobertura foram estimadas conforme o Índice de Vulnerabilidade Social Municipal, macrorregiões e regiões de saúde. Resultados A prevalência de mulheres não beneficiarias de planos privados de saúde variou de 38,1% a 94,2% entre regiões de saúde. A cobertura estadual foi 17,3% para todas as residentes e 23,8% para as não beneficiárias de planos privados. As maiores coberturas ocorreram nos municípios em maior vulnerabilidade social e nas regiões com maior prevalência de planos privados. Conclusões A prevalência de planos privados de saúde deve ser considerada em estudos da cobertura de serviços pelo Sistema Único de Saúde.

ABSTRACT Objectives To identify socioeconomic and regional inequalities of pap smear coverage in the state of Rio Grande do Sul. Methods An ecological study based on data of the 2011-2012 national health information system to estimate the annual coverage of pap smears for the overall female population of the state and for women without private health insurance. We estimated annual pap smear coverage according to the Municipal Social Vulnerability Index and health macro-regions and regions of the state. Results The percentage of women without private health insurance ranged from 38.1% to 94.2% in the health regions. Pap smear coverage was 17.3% for the overall female population and 23.8% for women without private health insurance. Pap smear coverage was higher in more socially vulnerable municipalities and regions with a higher percentage of women with private health insurance. Conclusions The prevalence of private health insurance should be considered in studies that address the coverage of the Brazilian Unified Health System (SUS).

RESUMEN Objetivos Identificar desigualdades socioeconómicas y regionales en la cobertura de exámenes citopatológicos del cuello uterino en Rio Grande do Sul. Métodos Estudio ecológico utilizó datos de los sistemas de información en salud de 2011-2012 para estimar coberturas anuales de exámenes para la totalidad de mujeres residentes y para no beneficiarias de planes privados de salud. Se estimaron las desigualdades según el Índice de Vulnerabilidad Social Municipal, las macroregiones y las regiones de salud. Resultados La prevalencia de mujeres no beneficiarias de planes privados de salud tuvo una variación de 38.1% a 94.2% entre las regiones de salud. La cobertura del estado fue de 17.3% para la totalidad de residentes y el 23.8% para no beneficiarias de planes privados. Las mayores coberturas sucedieron en los municipios de mayor vulnerabilidad social y regiones con mayor prevalencia de planes privados. Conclusiones La prevalencia de los planes privados de salud debe ser considerada en los estudios de cobertura de servicios del Sistema Único de Salud (SUS).

ABSTRACT Objectives To identify socioeconomic and regional inequalities of pap smear coverage in the state of Rio Grande do Sul. Methods An ecological study based on data of the 2011-2012 national health information system to estimate the annual coverage of pap smears for the overall female population of the state and for women without private health insurance. We estimated annual pap smear coverage according to the Municipal Social Vulnerability Index and health macro-regions and regions of the state. Results The percentage of women without private health insurance ranged from 38.1% to 94.2% in the health regions. Pap smear coverage was 17.3% for the overall female population and 23.8% for women without private health insurance. Pap smear coverage was higher in more socially vulnerable municipalities and regions with a higher percentage of women with private health insurance. Conclusions The prevalence of private health insurance should be considered in studies that address the coverage of the Brazilian Unified Health System (SUS).

RESUMEN Objetivos Identificar desigualdades socioeconómicas y regionales en la cobertura de exámenes citopatológicos del cuello uterino en Rio Grande do Sul. Métodos Estudio ecológico utilizó datos de los sistemas de información en salud de 2011-2012 para estimar coberturas anuales de exámenes para la totalidad de mujeres residentes y para no beneficiarias de planes privados de salud. Se estimaron las desigualdades según el Índice de Vulnerabilidad Social Municipal, las macroregiones y las regiones de salud. Resultados La prevalencia de mujeres no beneficiarias de planes privados de salud tuvo una variación de 38.1% a 94.2% entre las regiones de salud. La cobertura del estado fue de 17.3% para la totalidad de residentes y el 23.8% para no beneficiarias de planes privados. Las mayores coberturas sucedieron en los municipios de mayor vulnerabilidad social y regiones con mayor prevalencia de planes privados. Conclusiones La prevalencia de los planes privados de salud debe ser considerada en los estudios de cobertura de servicios del Sistema Único de Salud (SUS).

RESUMO Objetivos Identificar desigualdades socioeconômicas e regionais na cobertura de exames citopatológicos do colo do útero no Rio Grande do Sul. Métodos Estudo ecológico utilizou dados dos sistemas de informação em saúde de 2011-2012 para estimar coberturas anuais de exames para todas as mulheres residentes e para as não beneficiárias de planos privados de saúde. Desigualdades na cobertura foram estimadas conforme o Índice de Vulnerabilidade Social Municipal, macrorregiões e regiões de saúde. Resultados A prevalência de mulheres não beneficiarias de planos privados de saúde variou de 38,1% a 94,2% entre regiões de saúde. A cobertura estadual foi 17,3% para todas as residentes e 23,8% para as não beneficiárias de planos privados. As maiores coberturas ocorreram nos municípios em maior vulnerabilidade social e nas regiões com maior prevalência de planos privados. Conclusões A prevalência de planos privados de saúde deve ser considerada em estudos da cobertura de serviços pelo Sistema Único de Saúde.

OBJETIVO: o adenocarcinoma viloglandular (AVG) da cérvice foi identificado como uma variante do adenocarcinoma cervical que ocorre em mulheres jovens e traz um excelente prognóstico. Diante da escassez de estudos relacionados ao tema, nós relatamos seis casos de AVG de cérvice. MÉTODOS: acompanhamos a evolução de seis casos de AVG, no período de 1995 a 2006, no Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul (PUC-RS). Coletamos informações clínicas e histológicas de todas as pacientes e submetemos todas as peças cirúrgicas para revisão histológica. RESULTADOS: a idade média da apresentação foi de 43,5 anos (variando de 27 a 61 anos). Quatro pacientes submeteram-se à histerectomia radical de Wertheim-Meigs e linfadenectomia pélvica bilateral, uma submeteu-se a conização e subseqüente radioterapia e uma a linfadenectomia pélvica seguida de radioterapia. Todas as pacientes estão vivas e bem, sem evidência de recorrência. CONCLUSÕES: as implicações da terapia são discutidas. Propomos aqui a inclusão do estudo do padrão de envolvimento linfovascular na determinação diagnóstica do AVG. Assim, ao referenciarmos este diagnóstico, poderemos optar, com cautela, pela terapia conservadora, salvo particularidades de cada caso.

PURPOSE: the villoglandular adenocarcinoma (VGA) of the cervix has been identified as a variant of cervical adenocarcinoma that occurs in young women, which has an excellent prognosis. Considering the scarcity of studies related to the subject, we report six cases of VGA of the cervix. METHODS: we followed the development of six cases of VGA in the period from 1995 to 2006 at Hospital São Lucas of Pontifícia Universidade Católica do Rio Grande do Sul (PUC-RS). We collected clinical and histologic information of the patients and submitted all the surgical specimens to histological review. RESULTS: mean age at diagnosis was 43.5 years (range 27-61 years). Four patients were submitted to Wertheim-Meigs radical hysterectomy and bilateral pelvic lymphadenectomy, one to conization and subsequent radiotherapy and one to pelvic lymphadenectomy followed by radiotherapy. All the patients were alive and well at the time of this writing, without evidence of recurrence. CONCLUSIONS: the implications of therapy are discussed. We propose here the inclusion of the study of the pattern of lymphovascular involvement in determining the diagnosis of VGA. Thus, in referring to this diagnosis, we will be able to opt, with caution, for conservative therapy, except for particularities of each case.

OBJETIVOS: testar a hipótese de que o polimorfismo no códon 72 do gene TP53 é fator de risco para as lesões pré-malignas e malignas cervicais associadas ou não ao papilomavírus humano (HPV). MÉTODOS: foram incluídas amostras de cérvice uterina, para pesquisa de DNA de HPV e do polimorfismo no códon 72 da p53 com o uso da reação em cadeia da polimerase (PCR), de 155 pacientes que se submeteram à biópsia cervical. Foram formados três grupos de acordo com o diagnóstico histológico: lesão escamosa intra-epitelial de baixo grau (LSIL), lesão escamosa intra-epitelial de alto grau (HSIL) e carcinoma cervical. Aquelas pacientes sem alterações displásicas, citológicas e histológicas, foram consideradas controles. Para testar a associação entre o polimorfismo no códon 72 do gene TP53 e os grupos, foi utilizado o teste de chi2. Considerou-se como significativo o intervalo de confiança no nível de 95% (alfa=0,05). RESULTADOS: quarenta pacientes tiveram o diagnóstico histológico de carcinoma cervical, 18 tinham HSIL, 24 tinham LSIL e 73 foram consideradas controles. O genótipo Arg/Arg p53 foi encontrado em 60,0% das pacientes com câncer, 50,0% dos casos com HSIL, 45,8% dos casos com LSIL e em 45,2% dos controles. Não houve diferença significativa entre as proporções de cada genótipo da p53 nos diferentes grupos independente da presença do HPV (chi2: 3,7; p=0,716). CONCLUSÕES: nossos dados não suportam a hipótese de que o polimorfismo no códon 72 do gene TP53 é importante no desenvolvimento de lesões cervicais pré-malignas e malignas associadas ou não ao HPV.

PURPOSE: to test the hypothesis that gene TP53 codon 72 polymorphism is a risk factor for premalignant and malignant cervical lesions associated or not with human papillomavirus (HPV). METHODS: uterine cervical samples were collected for HPV DNA and TP53 codon 72 polymorphism tests from 155 patients who underwent cervical biopsy. Three groups were formed according to histological diagnosis: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL) and cervical carcinoma. Subjects without cytological and histological displasic changes were considered controls. To verify the association between the gene TP53 codon 72 polymorphism and the groups, the chi2 test was applied. Confidence interval was considered significant at 95% (alpha=0.05). RESULTS: forty subjects were found to present cervical carcinoma, 18 had HSIL, 24 had LSIL and 73 were grouped as controls. The genotype Arg/Arg p53 was found in 60% of the patients with cancer, in 50.0% of the cases with HSIL, 45.8% with LSIL, and in 45.2% of the controls. No significant differences were identified in the frequencies of p53 genotype between all groups, independently of the presence of HPV (chi2: 3.7; p=0.716). CONCLUSIONS: our data do not support hypothesis that the gene TP53 codon 72 polymorphism is important for the development of pre-malignant and malignant cervical lesions associated or not with HPV.